Last reviewed · How we verify
NCT04047030: MBTK
The Mobility Toolkit: Electronically Augmented Assessment of Functional Recovery Following Lower-extremity Trauma
trial testing None- Observational Study in Gait in 244 participants. Completed in 31 August 2024.
1 December 2023
Quick facts
| Lead sponsor | Major Extremity Trauma Research Consortium |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 244 |
| Start date | 1 January 2019 |
| Primary completion | 1 December 2023 |
| Estimated completion | 31 August 2024 |
| Sites | 10 locations across United States |
Drugs / interventions tested
- None- Observational Study
Conditions studied
- Gait — all drugs for Gait →
Sponsor
Major Extremity Trauma Research Consortium
Who can join
Adults 18 to 60, any sex, with Gait. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study will prospectively enroll and follow 300 participants ages 18-60 surgically treated for a lower-extremity articular injury including fractures of the tibial plateau, pilon, ankle, and calcaneus.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04047030
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of None- Observational Study
Trials testing the same drug.
- NCT03808038 — Symptoms of Lower Urinary Tract Dysfunction Protocol 2/Recall Study · completed
Other recruiting trials for Gait
Currently open trials in the same condition.
- NCT07174973 — Innovative Approaches to Enhance Balance and Neuroplasticity in Multiple Sclerosis · NA · recruiting
- NCT07085416 — Sensor Ankle Brace for Special Operations Rehabilitation · NA · recruiting
- NCT07155577 — Effects of Pes Planus on Gait at Different Inclines · recruiting
- NCT07167472 — Effects of Heel Height on Gait Parameters · recruiting
- NCT07152262 — Effects of Menstrual Cycle Phases on Gait, Pelvis, and Sleep · recruiting
Other Major Extremity Trauma Research Consortium trials
Trials by the same sponsor.
- NCT06337292 — Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures · Phase 3 · recruiting
- NCT05889559 — Evaluation of the Diagnostic and Therapeutic Value of Tissue Ultrafiltration in Patients at Risk of Acute Compartment Sy · NA · recruiting
- NCT04789044 — Evaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion) · Phase 2 · recruiting
- NCT04839497 — Multicenter Trial Evaluating the Safety and Efficacy of Autologous Volar Fibroblast Injection Into the Terminal Limb of · Phase 2 · recruiting
- NCT05143476 — Serum-Protein-Based Indices for the Progression of Fracture Healing and Nonunion · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04047030 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Major Extremity Trauma Research Consortium
- Last refreshed: 6 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04047030.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing